L-2-hydroxyglutaric aciduria: a report of 29 patients.
L-2-hydroxyglutaric aciduria (L2HGA) is a chronic slowly progressive neurodegenerative disease characterized mainly by psychomotor developmental delay and cerebellar dysfunction. We report the clinical, biochemical, and neuroimaging features of 29 patients from 22 families. The mean age at the time of diagnosis was 13.4 years (2.5-32 years). The mean follow-up period of patients was four years (1.5-16 years). The main clinical findings were mental retardation and cerebellar involvement with ataxic gait and intentional tremor. Additional findings were mental retardation, macrocephaly and seizures. Diagnosis was confirmed by increased urinary excretion of L-2-hydroxyglutaric acid in all patients and highly specific magnetic resonance imaging (MRI) pattern showing subcortical leukoencephalopathy with bilateral high signal intensity in dentate nuclei and putamens. During the follow-up period, all patients had a static encephalopathy course. The underlying metabolic defect and the possible role of L-2-hydroxyglutaric acid are studied in a subgroup of these families and under evaluation for publication.
Topçu
Meral
M
Section of Neurology, Department of Pediatrics, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Aydin
Omer Faruk
OF
Yalçinkaya
Cengiz
C
Haliloğlu
Göknur
G
Aysun
Sabiha
S
Anlar
Banu
B
Topaloğlu
Haluk
H
Turanli
Güzide
G
Yalnizoğlu
Dilek
D
Kesimer
Mehmet
M
Coşkun
Turgay
T
D000293:Adolescent; D000328:Adult; D001921:Brain / Q000000981:diagnostic imaging / Q000473:pathology; D001927:Brain Diseases / Q000209:etiology / Q000523:psychology / Q000652:urine; D002648:Child; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D005977:Glutarates / Q000378:metabolism / Q000652:urine*; D006801:Humans; D007223:Infant; D007360:Intelligence; D008279:Magnetic Resonance Imaging; D008297:Male; D008661:Metabolism, Inborn Errors / Q000150:complications / Q000175:diagnosis / Q000652:urine*; D011859:Radiography
D005977:Glutarates; C019417:alpha-hydroxyglutarate